The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CMO Peptide Market Research Report 2025
Synopsis
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
The global CMO Peptide market was valued at US$ 2686.3 million in 2023 and is anticipated to reach US$ 7322.2 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.
This report aims to provide a comprehensive presentation of the global market for CMO Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO Peptide.
Report Scope
The CMO Peptide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CMO Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CMO Peptide companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
AmbioPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific
Segment by Type
APIs and Intermediates
FDF
Segment by Application
Commercial
Academic Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CMO Peptide companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
The global CMO Peptide market was valued at US$ 2686.3 million in 2023 and is anticipated to reach US$ 7322.2 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.
This report aims to provide a comprehensive presentation of the global market for CMO Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO Peptide.
Report Scope
The CMO Peptide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CMO Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CMO Peptide companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
AmbioPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific
Segment by Type
APIs and Intermediates
FDF
Segment by Application
Commercial
Academic Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CMO Peptide companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CMO Peptide Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 APIs and Intermediates
1.2.3 FDF
1.3 Market by Application
1.3.1 Global CMO Peptide Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CMO Peptide Market Perspective (2019-2030)
2.2 CMO Peptide Growth Trends by Region
2.2.1 Global CMO Peptide Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CMO Peptide Historic Market Size by Region (2019-2024)
2.2.3 CMO Peptide Forecasted Market Size by Region (2025-2030)
2.3 CMO Peptide Market Dynamics
2.3.1 CMO Peptide Industry Trends
2.3.2 CMO Peptide Market Drivers
2.3.3 CMO Peptide Market Challenges
2.3.4 CMO Peptide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CMO Peptide Players by Revenue
3.1.1 Global Top CMO Peptide Players by Revenue (2019-2024)
3.1.2 Global CMO Peptide Revenue Market Share by Players (2019-2024)
3.2 Global CMO Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CMO Peptide Revenue
3.4 Global CMO Peptide Market Concentration Ratio
3.4.1 Global CMO Peptide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMO Peptide Revenue in 2023
3.5 CMO Peptide Key Players Head office and Area Served
3.6 Key Players CMO Peptide Product Solution and Service
3.7 Date of Enter into CMO Peptide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CMO Peptide Breakdown Data by Type
4.1 Global CMO Peptide Historic Market Size by Type (2019-2024)
4.2 Global CMO Peptide Forecasted Market Size by Type (2025-2030)
5 CMO Peptide Breakdown Data by Application
5.1 Global CMO Peptide Historic Market Size by Application (2019-2024)
5.2 Global CMO Peptide Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CMO Peptide Market Size (2019-2030)
6.2 North America CMO Peptide Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CMO Peptide Market Size by Country (2019-2024)
6.4 North America CMO Peptide Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CMO Peptide Market Size (2019-2030)
7.2 Europe CMO Peptide Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CMO Peptide Market Size by Country (2019-2024)
7.4 Europe CMO Peptide Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CMO Peptide Market Size (2019-2030)
8.2 Asia-Pacific CMO Peptide Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CMO Peptide Market Size by Region (2019-2024)
8.4 Asia-Pacific CMO Peptide Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CMO Peptide Market Size (2019-2030)
9.2 Latin America CMO Peptide Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CMO Peptide Market Size by Country (2019-2024)
9.4 Latin America CMO Peptide Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CMO Peptide Market Size (2019-2030)
10.2 Middle East & Africa CMO Peptide Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CMO Peptide Market Size by Country (2019-2024)
10.4 Middle East & Africa CMO Peptide Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Detail
11.1.2 Bachem Business Overview
11.1.3 Bachem CMO Peptide Introduction
11.1.4 Bachem Revenue in CMO Peptide Business (2019-2024)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Detail
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide CMO Peptide Introduction
11.2.4 PolyPeptide Revenue in CMO Peptide Business (2019-2024)
11.2.5 PolyPeptide Recent Development
11.3 USV Peptides
11.3.1 USV Peptides Company Detail
11.3.2 USV Peptides Business Overview
11.3.3 USV Peptides CMO Peptide Introduction
11.3.4 USV Peptides Revenue in CMO Peptide Business (2019-2024)
11.3.5 USV Peptides Recent Development
11.4 Thermofischer
11.4.1 Thermofischer Company Detail
11.4.2 Thermofischer Business Overview
11.4.3 Thermofischer CMO Peptide Introduction
11.4.4 Thermofischer Revenue in CMO Peptide Business (2019-2024)
11.4.5 Thermofischer Recent Development
11.5 Bio Basic
11.5.1 Bio Basic Company Detail
11.5.2 Bio Basic Business Overview
11.5.3 Bio Basic CMO Peptide Introduction
11.5.4 Bio Basic Revenue in CMO Peptide Business (2019-2024)
11.5.5 Bio Basic Recent Development
11.6 JPT
11.6.1 JPT Company Detail
11.6.2 JPT Business Overview
11.6.3 JPT CMO Peptide Introduction
11.6.4 JPT Revenue in CMO Peptide Business (2019-2024)
11.6.5 JPT Recent Development
11.7 Genscript
11.7.1 Genscript Company Detail
11.7.2 Genscript Business Overview
11.7.3 Genscript CMO Peptide Introduction
11.7.4 Genscript Revenue in CMO Peptide Business (2019-2024)
11.7.5 Genscript Recent Development
11.8 Xinbang Pharma
11.8.1 Xinbang Pharma Company Detail
11.8.2 Xinbang Pharma Business Overview
11.8.3 Xinbang Pharma CMO Peptide Introduction
11.8.4 Xinbang Pharma Revenue in CMO Peptide Business (2019-2024)
11.8.5 Xinbang Pharma Recent Development
11.9 ScinoPharm
11.9.1 ScinoPharm Company Detail
11.9.2 ScinoPharm Business Overview
11.9.3 ScinoPharm CMO Peptide Introduction
11.9.4 ScinoPharm Revenue in CMO Peptide Business (2019-2024)
11.9.5 ScinoPharm Recent Development
11.10 AmbioPharm
11.10.1 AmbioPharm Company Detail
11.10.2 AmbioPharm Business Overview
11.10.3 AmbioPharm CMO Peptide Introduction
11.10.4 AmbioPharm Revenue in CMO Peptide Business (2019-2024)
11.10.5 AmbioPharm Recent Development
11.11 SN Biopharm
11.11.1 SN Biopharm Company Detail
11.11.2 SN Biopharm Business Overview
11.11.3 SN Biopharm CMO Peptide Introduction
11.11.4 SN Biopharm Revenue in CMO Peptide Business (2019-2024)
11.11.5 SN Biopharm Recent Development
11.12 CBL
11.12.1 CBL Company Detail
11.12.2 CBL Business Overview
11.12.3 CBL CMO Peptide Introduction
11.12.4 CBL Revenue in CMO Peptide Business (2019-2024)
11.12.5 CBL Recent Development
11.13 Piramal Pharma
11.13.1 Piramal Pharma Company Detail
11.13.2 Piramal Pharma Business Overview
11.13.3 Piramal Pharma CMO Peptide Introduction
11.13.4 Piramal Pharma Revenue in CMO Peptide Business (2019-2024)
11.13.5 Piramal Pharma Recent Development
11.14 CordenPharma
11.14.1 CordenPharma Company Detail
11.14.2 CordenPharma Business Overview
11.14.3 CordenPharma CMO Peptide Introduction
11.14.4 CordenPharma Revenue in CMO Peptide Business (2019-2024)
11.14.5 CordenPharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Detail
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific CMO Peptide Introduction
11.15.4 CPC Scientific Revenue in CMO Peptide Business (2019-2024)
11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global CMO Peptide Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of APIs and Intermediates
Table 3. Key Players of FDF
Table 4. Global CMO Peptide Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global CMO Peptide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global CMO Peptide Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global CMO Peptide Market Share by Region (2019-2024)
Table 8. Global CMO Peptide Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global CMO Peptide Market Share by Region (2025-2030)
Table 10. CMO Peptide Market Trends
Table 11. CMO Peptide Market Drivers
Table 12. CMO Peptide Market Challenges
Table 13. CMO Peptide Market Restraints
Table 14. Global CMO Peptide Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global CMO Peptide Market Share by Players (2019-2024)
Table 16. Global Top CMO Peptide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO Peptide as of 2023)
Table 17. Ranking of Global Top CMO Peptide Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by CMO Peptide Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CMO Peptide Product Solution and Service
Table 21. Date of Enter into CMO Peptide Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CMO Peptide Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global CMO Peptide Revenue Market Share by Type (2019-2024)
Table 25. Global CMO Peptide Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global CMO Peptide Revenue Market Share by Type (2025-2030)
Table 27. Global CMO Peptide Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global CMO Peptide Revenue Market Share by Application (2019-2024)
Table 29. Global CMO Peptide Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global CMO Peptide Revenue Market Share by Application (2025-2030)
Table 31. North America CMO Peptide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America CMO Peptide Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America CMO Peptide Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe CMO Peptide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe CMO Peptide Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe CMO Peptide Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific CMO Peptide Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific CMO Peptide Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific CMO Peptide Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America CMO Peptide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America CMO Peptide Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America CMO Peptide Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa CMO Peptide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa CMO Peptide Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa CMO Peptide Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bachem Company Detail
Table 47. Bachem Business Overview
Table 48. Bachem CMO Peptide Product
Table 49. Bachem Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 50. Bachem Recent Development
Table 51. PolyPeptide Company Detail
Table 52. PolyPeptide Business Overview
Table 53. PolyPeptide CMO Peptide Product
Table 54. PolyPeptide Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 55. PolyPeptide Recent Development
Table 56. USV Peptides Company Detail
Table 57. USV Peptides Business Overview
Table 58. USV Peptides CMO Peptide Product
Table 59. USV Peptides Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 60. USV Peptides Recent Development
Table 61. Thermofischer Company Detail
Table 62. Thermofischer Business Overview
Table 63. Thermofischer CMO Peptide Product
Table 64. Thermofischer Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 65. Thermofischer Recent Development
Table 66. Bio Basic Company Detail
Table 67. Bio Basic Business Overview
Table 68. Bio Basic CMO Peptide Product
Table 69. Bio Basic Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 70. Bio Basic Recent Development
Table 71. JPT Company Detail
Table 72. JPT Business Overview
Table 73. JPT CMO Peptide Product
Table 74. JPT Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 75. JPT Recent Development
Table 76. Genscript Company Detail
Table 77. Genscript Business Overview
Table 78. Genscript CMO Peptide Product
Table 79. Genscript Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 80. Genscript Recent Development
Table 81. Xinbang Pharma Company Detail
Table 82. Xinbang Pharma Business Overview
Table 83. Xinbang Pharma CMO Peptide Product
Table 84. Xinbang Pharma Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 85. Xinbang Pharma Recent Development
Table 86. ScinoPharm Company Detail
Table 87. ScinoPharm Business Overview
Table 88. ScinoPharm CMO Peptide Product
Table 89. ScinoPharm Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 90. ScinoPharm Recent Development
Table 91. AmbioPharm Company Detail
Table 92. AmbioPharm Business Overview
Table 93. AmbioPharm CMO Peptide Product
Table 94. AmbioPharm Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 95. AmbioPharm Recent Development
Table 96. SN Biopharm Company Detail
Table 97. SN Biopharm Business Overview
Table 98. SN Biopharm CMO Peptide Product
Table 99. SN Biopharm Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 100. SN Biopharm Recent Development
Table 101. CBL Company Detail
Table 102. CBL Business Overview
Table 103. CBL CMO Peptide Product
Table 104. CBL Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 105. CBL Recent Development
Table 106. Piramal Pharma Company Detail
Table 107. Piramal Pharma Business Overview
Table 108. Piramal Pharma CMO Peptide Product
Table 109. Piramal Pharma Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 110. Piramal Pharma Recent Development
Table 111. CordenPharma Company Detail
Table 112. CordenPharma Business Overview
Table 113. CordenPharma CMO Peptide Product
Table 114. CordenPharma Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 115. CordenPharma Recent Development
Table 116. CPC Scientific Company Detail
Table 117. CPC Scientific Business Overview
Table 118. CPC Scientific CMO Peptide Product
Table 119. CPC Scientific Revenue in CMO Peptide Business (2019-2024) & (US$ Million)
Table 120. CPC Scientific Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CMO Peptide Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CMO Peptide Market Share by Type: 2023 VS 2030
Figure 3. APIs and Intermediates Features
Figure 4. FDF Features
Figure 5. Global CMO Peptide Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global CMO Peptide Market Share by Application: 2023 VS 2030
Figure 7. Commercial Case Studies
Figure 8. Academic Research Case Studies
Figure 9. Other Case Studies
Figure 10. CMO Peptide Report Years Considered
Figure 11. Global CMO Peptide Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global CMO Peptide Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global CMO Peptide Market Share by Region: 2023 VS 2030
Figure 14. Global CMO Peptide Market Share by Players in 2023
Figure 15. Global Top CMO Peptide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO Peptide as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by CMO Peptide Revenue in 2023
Figure 17. North America CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America CMO Peptide Market Share by Country (2019-2030)
Figure 19. United States CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe CMO Peptide Market Share by Country (2019-2030)
Figure 23. Germany CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific CMO Peptide Market Share by Region (2019-2030)
Figure 31. China CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America CMO Peptide Market Share by Country (2019-2030)
Figure 39. Mexico CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa CMO Peptide Market Share by Country (2019-2030)
Figure 43. Turkey CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia CMO Peptide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Bachem Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 46. PolyPeptide Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 47. USV Peptides Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 48. Thermofischer Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 49. Bio Basic Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 50. JPT Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 51. Genscript Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 52. Xinbang Pharma Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 53. ScinoPharm Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 54. AmbioPharm Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 55. SN Biopharm Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 56. CBL Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 57. Piramal Pharma Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 58. CordenPharma Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 59. CPC Scientific Revenue Growth Rate in CMO Peptide Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
